Imperial College London
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Oesophagectomy and Chest Wall and Respiratory Function
Recruiting
- Conditions
- Esophageal CancerRespiratory Function LossEsophagectomy
- Interventions
- Other: 3D motion capture systemOther: Incentive spirometryOther: Questionnaires
- First Posted Date
- 2019-02-08
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 100
- Registration Number
- NCT03835273
- Locations
- 🇬🇧
Charing Cross Hospital, London, United Kingdom
Combining Physical Therapy With Vestibular Stimulation to Improve Postural Stability in Pusher's Syndrome
Not Applicable
Withdrawn
- Conditions
- Pusher Syndrome
- Interventions
- Device: Galvanic Vestibular StimulationOther: Standard Physiotherapy
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT03831594
- Locations
- 🇬🇧
Imperial College London, London, United Kingdom
HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Radiation: [18F]GE-226
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 24
- Registration Number
- NCT03827317
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens
Phase 1
Completed
- Conditions
- HIV-1-infection
- Interventions
- Biological: ConM SOSIPBiological: EDC ConM SOSIPBiological: ConS UFOBiological: EDC ConS UFOBiological: 763 SOSIPBiological: AMC011 SOSIPBiological: Mosaic SOSIPs
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 117
- Registration Number
- NCT03816137
- Locations
- 🇬🇧
NIHR Imperial Clinical Resarch Facility, London, United Kingdom
Anxiety and Distress Levels in Women With Suspected Endometrial Cancer
Completed
- Conditions
- StressEndometrial CancerUterine CancerAnxietyCancerPsychological
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2020-07-14
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 250
- Registration Number
- NCT03813719
- Locations
- 🇬🇧
Queen Charlotte and Hammersmith Hospital, London, United Kingdom
Ablation of Low Voltage Regions in Persistent Atrial Fibrillation
Not Applicable
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Procedure: Pulmonary Vein IsolationProcedure: Low voltage ablation
- First Posted Date
- 2019-01-22
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 80
- Registration Number
- NCT03811938
- Locations
- 🇬🇧
Hammersmith Hospital, London, United Kingdom
Mobile Learning to Improve Clinician's Ability to Break Bad News
Not Applicable
Completed
- Conditions
- Education
- Interventions
- Other: VitalTips mobile application
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 17
- Registration Number
- NCT03804918
- Locations
- 🇬🇧
Barts Health NHS Trust, London, United Kingdom
🇬🇧Imperial College Healthcare NHS Trust, London, United Kingdom
🇬🇧Bupa Cromwell Hospital, London, United Kingdom
TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)
Not Applicable
Recruiting
- Conditions
- Atopic Dermatitis Eczema
- Interventions
- Device: Nocturnal Temperature controlled Laminar Airflow (TLA) TreatmentDevice: Placebo TLA Device
- First Posted Date
- 2019-01-07
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 96
- Registration Number
- NCT03795506
- Locations
- 🇬🇧
IMPERIAL COLLEGE HEALTHCARE NHS Trust, London, United Kingdom
Combined Ranibizumab and Iluvien for Diabetic Macular Oedema
Phase 2
Withdrawn
- Conditions
- Diabetic Macular EdemaDiabetes
- Interventions
- Drug: Iluvien 0.19 MG Drug ImplantProcedure: Sham Intravitreal InjectionDrug: Ranibizumab Injection [Lucentis]
- First Posted Date
- 2018-12-21
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT03784443
IL-1 Signal Inhibition in Alcoholic Hepatitis
Phase 2
Recruiting
- Conditions
- Alcoholic Hepatitis
- Interventions
- Drug: Canakinumab 150mg/ml solution for injectionDrug: Placebo
- First Posted Date
- 2018-12-13
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 1300
- Registration Number
- NCT03775109
- Locations
- 🇬🇧
Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
🇬🇧Plymouth Hospitals NHS Trust, Plymouth, United Kingdom
🇬🇧Aintree University Hospital, Liverpool, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath